Triiodothyronine attenuates estradiol-induced increases in dopamine D-2 receptor number in rat anterior pituitary

Brain Research

Volumn 712, Issue 1, 1996, Pages 148-152

  Nedvídková, Jara ^a   Pacák, Karel ^a,b   Nedvídek, Jan ^c   Goldstein, David S ^b   Schreiber, Vratislav ^c  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

cAMP; Estrogen; Pituitary D 2 receptor; Prolactin; T3; Thyrotrophin; Thyroxine

Indexed keywords

AGOFOLIN DEPOT; CYCLIC AMP; DOPAMINE 2 RECEPTOR; ESTRADIOL; LIOTHYRONINE; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERPROLACTINEMIA; HYPOPHYSIS TUMOR; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION;

EID: 0342313507     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01524-8     Document Type: Article

References (29)

1. Ali, S.F. and Peck Jr., E.J., Modulation of anterior pituitary dopamine receptors by estradiol 17-β: dose-response relationship, J. Neurosci. Res., 13 (1985) 497-507.
2. Arita, J., Kojima, Y. and Kimura, F., Enhanced dopamine synthesis and release in vitro in the median eminence of rat hypothalamus are associated with involution of estradiol-induced pituitary tumors, Endocrinology, 124 (1989) 1998-2004.
3. Bevan, J.S., Webster, J., Burke, C.W. and Scanlon, M.F., Dopamine agonists and pituitary tumor shrinkage, Endocr. Rev., 123 (1992) 220-240.
4. Bression, D., Brandi, A.M., Le Dafniet, M., Cesselin, F., Hamon, M., Martinet, M., Kerdelhue, B. and Peillon, F., Modification of the high and low affinity domperidone-binding sites in chronic estrogenized rats, Endocrinology, 113 (1983) 1799-1805.
5. 3H-dihydroergocryptine binding with the dopaminergic control of prolactin release, J. Biol. Chem., 253 (1978) 2244-2253.
6. Casanueva, F., Cocchi, D., Locatelli, V., Flauto, C., Zambotti, F., Bestetti, G., Rossi, G.L. and Muller, E., Defective central nervous system dopaminergic function in rats with estrogen-induced pituitary tumors, as assessed by plasma prolactin concentrations, Endocrinology, 110 (1982) 590-599.
7. Demarest, K.T., Riegle, G.D. and Moore, K.E., Long-term treatment with estradiol induced reversible alterations in tuberoinfundibular dopaminergic neurons: a decrease responsiveness to prolactin, Neuroendocrinology, 39 (1984) 193-200.
8. Di Paolo, T., Daigle, M. and Barden, N., Decreased tuberoin-fundibular and pituitary dopamine and dihydroxyphenylacetic acid concentrations in rats with estrogen-induced pituitary tumors, Neurosci. Lett., 54 (1985) 251-256.
9. DiPaolo, T. and Falardeau, P., Dopamine receptors in rat pituitary and estradiol-induced pituitary tumor: effect of chronic treatment with bromocriptine, Biochem. Biophysic. Res. Commun., 123 (1984) 312-316.
10. Dušková, J. and Schreiber, V., Nucleolar inhibition in prolactin cells after combined thyroid hormone plus lisuride treatment in estrogenized rats, Endocrinol. Exp., 23 (1989) 185-194.
11. Elias, K.A. and Weiner, R.I., Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fischer 344 rats, Endocrinology, 120 (1987) 617-621.
12. Ferretti, C., Blengio, M., Ghi, P., Racca, S., Genazzani, E. and Portaleone, P., Tamoxifen counteracts estradiol induced effects on striatal and hypophyseal dopamine receptors, Life Sci., 42 (1988) 2457-2465.
13. Gibbs, D.M. and Neill, J.D., Dopamine levels in hypophysial stalk blood in the rat are sufficient to inhibit prolactin secretion in vivo, Endocrinology, 102 (1978) 1895-1900.
14. Jones, E.E. and Naftolin, F., Estrogen effects on the tuberoin-fundibular dopaminergic system in the female rat brain, Brain Res., 510 (1990) 84-91.
15. Kalberman, L.E., Machiavelli, G., Di Nicola, A.F., Weisenberg, L. and Burdman, J.A., Synthesis of DNA in estrogen-induced pituitary tumors: effects of bromocriptine, J. Endocrinol., 87 (1980) 221-224.
16. Levesque, D. and Di Paolo, T., Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovarectomized rats, Mol. Pharmacol., 39 (1991) 659-665.
17. Lin, C., Lin, S-C., Chang, C-P. and Rosenfeld, M.G., Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth, Nature, 360 (1992) 765-768.
18. Maurer, R.A., Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation on cultured pituitary cells, J. Biol. Chem., 255 (1980) 8092-8097.
19. 2 dopamine receptor in rat anterior pituitary gland, Endocrinology, 124 (1989) 346-355.
20. Munson, P.J. and Rodberd, D., Ligand: a versatile computerized approach for characterization of ligand-binding systems, Anal. Biochem., 107 (1980) 220-239.
21. Murdoch, G.H., Rosenfeld, M.G. and Evans, R.M., Eukaryotic transcriptional regulation and chromatin-associated protein phosphorylation by cyclic AMP, Science, 218 (1982) 1315-1317.
22. Nedvídková, J. and Felt, V., Radioimunologicke urceni thyroxinu v seru bez extrakce, Cas. Lek. Ces., 116 (1977) 1327-1330.
23. Nedvídková, J. and Schreiber, V., The increase in cAMP and cGMP levels in the oestrogenized rat hypophysis, Physiol. Res., 41 (1992) 279-284.
24. Ruvkin, G., A molecular growth industry, Nature, 360 (1992) 711-712.
25. Sarkar, D.K., Gottschall, P.E. and Meites, J., Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors, Science, 218 (1982) 694-686.
26. Sarkar, D.K., Gottschall, P.E., Xie, Q. and Meites, J., Reduced tuberoinfundibular dopaminergic function in rats with in situ prolactin-secreting pituitary tumors, Neuroendocrinology, 38 (1984) 498-503.
27. 125-J-thyroxine by adenohypophysial proteins, Physiol. Bohemoslov., 19 (1970) 501-509.
28. Sibley, D.R., De Lean, A. and Creese, I., Anterior pituitary dopamine receptors demonstration of interconvertible high and low affinity states of the DA-2 dopamine receptor, J. Biol. Chem., 257 (1982) 6351-6359.
29. Woods, W.F., Johnston, J.M. and Johnston, D.G., Dopamine, the dopamine D2 receptor and pituitary tumours, Clin. Endocrinol., 35 (1991) 455-466.